BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23123368)

  • 1. Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy.
    Nakagawa T; Hara T; Kawahara T; Ogata Y; Nakanishi H; Komiyama M; Arai E; Kanai Y; Fujimoto H
    J Urol; 2013 Apr; 189(4):1275-81. PubMed ID: 23123368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
    Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF
    J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy.
    Bruins HM; Wopat R; Mitra AP; Cai J; Miranda G; Skinner EC; Daneshmand S
    BJU Int; 2013 Mar; 111(3 Pt B):E37-42. PubMed ID: 22974410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma.
    Nakagawa T; Kanai Y; Nakanishi H; Komiyama M; Fujimoto H
    Jpn J Clin Oncol; 2012 Nov; 42(11):1066-72. PubMed ID: 22914320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper urinary tract recurrence following radical cystectomy for bladder cancer.
    Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
    Int J Urol; 2007 Jun; 14(6):496-9. PubMed ID: 17593092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
    Rink M; Lee DJ; Kent M; Xylinas E; Fritsche HM; Babjuk M; Brisuda A; Hansen J; Green DA; Aziz A; Cha EK; Novara G; Chun FK; Lotan Y; Bastian PJ; Tilki D; Gontero P; Pycha A; Baniel J; Mano R; Ficarra V; Trinh QD; Tagawa ST; Karakiewicz PI; Scherr DS; Sjoberg DD; Shariat SF;
    BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late recurrence after radical cystectomy: patterns, risk factors and outcomes.
    Linder BJ; Boorjian SA; Hudolin T; Cheville JC; Thapa P; Tarrell RF; Frank I
    J Urol; 2014 May; 191(5):1256-61. PubMed ID: 24333110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder.
    May M; Bastian PJ; Brookman-May S; Fritsche HM; Bolenz C; Gilfrich C; Otto W; Trojan L; Herrmann E; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
    J Urol; 2012 Apr; 187(4):1210-4. PubMed ID: 22335861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
    Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis.
    Knoedler JJ; Boorjian SA; Kim SP; Weight CJ; Thapa P; Tarrell RF; Cheville JC; Frank I
    J Urol; 2012 Oct; 188(4):1115-9. PubMed ID: 22901583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
    Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
    J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
    J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.